Record Date For 2:1 Bonus Issue: Small Cap Pharma Stock With 180% Return In 1-Yr Fixes Date

Small Cap stock with multibagger returns, Zim Laboratories Ltd has decided record date for 2:1 bonus issue. Zim Laboratories Ltd operates in Pharmaceuticals sector and has a market capitalisation of Rs 553 crore. Check key details below pertaining to bonus issue:

1. Zim Laboratories Ltd Sets Bonus Issue Record Date

The board of directors of the company said in the BSE filing, "Pursuant to Regulation 42 of Listing Regulations, the Board of Directors have fixed Thursday, 22nd December, 2022 as the Record Date for the purpose of determining the Members who shall be entitled for allotment of bonus equity shares in the ratio of 2 :1 i.e. 2 (Two) new fully paid-up equity shares of Rs. 10/- each for every 1 (One) fully paid-up equity share of Rs. 10/- each held by the existing Members of the Company."

Therefore, the record date is December 22, 2022 for 2:1 bonus issue.  

2. Zim Laboratories Ltd Stock Performance

The current market price of the stock is Rs 340 apiece with an intraday decline of 1.25%. The stock's 52-week high is Rs 388 apiece and 52-week low is Rs 110 apiece, respectively.

3. Zim Laboratories Ltd Return

The stock has given 35% return in last 3-months, 180% return in last 1-year, and 424% return in last 3-years.

4. About Zim Laboratories

The company was incorporated in 1984 and engaged in developing, manufacturing, and supplying differentiated generic products in the oral solid dosage forms, both as pre-formulation intermediates as well as finished formulations for certain key therapeutic segments.

It offers both pharmaceutical and nutraceutical products. It has in-house R&D capabilities to offer a range of non-infringing drug delivery solutions based on process technologies that enable patient compliance thereby reducing the cost of treatment.

Disclaimer

The stock gives details relates to bonus issue and record date. Greynium Information Technologies and the author are not liable for any losses caused as a result of decisions based on the article. Goodreturns.in advises users to check with certified experts before taking any investment decision.